• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Biotech Market
Biotech News
Biotech Stocks
  • Biotech Market
  • Biotech News
  • Biotech Stocks

Novoheart Reports Q1 2018 Financial Results

Bryan Mc Govern
Nov. 29, 2017 08:35AM PST
Biotech Investing

Novoheart Holdings announced its financial results for the first quarter of 2018.

Novoheart Holdings (TSXV:NVH) announced its financial results for the first quarter of 2018.
As quoted in the press release:

“This first quarter as a public company was very much about ensuring the long-term viability of Novoheart well into the future and I adamantly believe we accomplished this through several channels,” said Dr. Ronald Li, CEO of Novoheart. “The initial capital secured in the first quarter has allowed us to establish locations in both North America and Hong Kong, two locations that are critical for us to be active in. Furthermore, we have actively invested in infrastructure that will allow us to be at the forefront of innovation and further advance our commercial scalability in the near future.”
Q1 2018 Highlights:

  • Completed listing on the TSX Venture Exchange by way of a reverse takeover and a concurrent financing of C$7.15 million
  • New R&D location at The Cove in Irvine, California
  • Expansion of lab and office facilities at Hong Kong Science Park

Click here to read the full press release.

Source: www.marketwired.com

financial results hong kong
The Conversation (0)

Go Deeper

AI Powered
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

Nanalysis Reports First Quarter 2022 Results

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Biotech Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES